
Published Oct 8, 2026 · Updated Oct 8, 2026
Tirzepatide Units to mg: How Many Units Is 2.5 mg, and How Many mg Is 20 or 40 Units?
How many units is 2.5 mg of tirzepatide, and how many mg is 20 or 40 units? Convert with the formula and charts, then check your vial's concentration.
People ask how many units 2.5 mg of tirzepatide is because compounded tirzepatide is often drawn up with an insulin syringe marked in units, while prescriptions are written in milligrams. On a U-100 insulin syringe, 100 units equal 1 mL, so the number of units in 2.5 mg of tirzepatide depends entirely on the concentration printed on the vial: 25 units at 10 mg/mL, 50 units at 5 mg/mL.1 Every table below is arithmetic on that scale, not a prescription. Always check your vial's concentration and follow your prescriber's instructions.
Why units and milligrams get confused
A "unit" on an insulin syringe is a volume mark, not a dose of drug. The FDA's dosing-error alert uses the U-100 scale, where 5 units equal 0.05 mL.1 A milligram is the amount of tirzepatide itself. The link between the two is the concentration of the liquid, in mg per mL.
The FDA has warned that this mix-up causes real harm. With compounded semaglutide, a related GLP-1 drug sold the same way, the agency received reports of patients giving themselves 5 to 20 times the intended dose.1 In one case a provider wrote 25 units when the intended dose of 0.25 mg was 5 units, and the patient had severe vomiting.1 Reported effects included nausea, vomiting, abdominal pain, fainting, dehydration, acute pancreatitis and gallstones, and some patients were hospitalized.1
The tirzepatide units-to-mg formula
To convert units to mg, divide the units by 100 and multiply by the concentration in mg/mL. On a U-100 syringe, 100 units is 1 mL, so 1 unit is 0.01 mL.1
- Units to mg: mg = (units ÷ 100) × mg/mL
- mg to units: units = (mg ÷ mg/mL) × 100
- Units to mL: mL = units ÷ 100
Example: a vial labeled 10 mg/mL and a dose of 20 units. 20 ÷ 100 = 0.2 mL, and 0.2 mL × 10 mg/mL = 2 mg.1 Our dose converter runs the same math for any concentration.
How many units is 2.5 mg of tirzepatide?
2.5 mg of tirzepatide is 50 units at 5 mg/mL, 25 units at 10 mg/mL, about 16.7 units at 15 mg/mL and 12.5 units at 20 mg/mL.1 The same dose can be very different volumes, which is why the vial label matters more than any chart.
The table converts each FDA-approved tirzepatide dose strength into units at four example concentrations.21 These are arithmetic examples, not dosing advice.
*More than 100 units, which is more than a full 1 mL U-100 syringe.1
How many units is 5 mg or 7.5 mg of tirzepatide?
5 mg is 50 units at 10 mg/mL and 25 units at 20 mg/mL; 7.5 mg is 75 units at 10 mg/mL and 37.5 units at 20 mg/mL.1 At 5 mg/mL, 5 mg fills a whole 1 mL syringe (100 units).1
How many units is 10 mg, 12.5 mg or 15 mg of tirzepatide?
At 20 mg/mL, 10 mg is 50 units, 12.5 mg is 62.5 units and 15 mg is 75 units.1 At 10 mg/mL, 10 mg is 100 units, and 12.5 mg or 15 mg would not fit in a single 1 mL syringe.1 The FDA-approved maximum tirzepatide dose is 15 mg once weekly.26
How many mg is 20 units of tirzepatide?
20 units of tirzepatide is 0.2 mL, which holds 1 mg at 5 mg/mL, 2 mg at 10 mg/mL, 3 mg at 15 mg/mL and 4 mg at 20 mg/mL.1 Without the concentration, the question has no single answer.
Arithmetic on the U-100 scale; check your own vial.1
How many mg is 40 units of tirzepatide?
40 units is 0.4 mL: 2 mg at 5 mg/mL, 4 mg at 10 mg/mL, 6 mg at 15 mg/mL and 8 mg at 20 mg/mL.1
How many mg is 50 units of tirzepatide?
50 units is 0.5 mL: 2.5 mg at 5 mg/mL, 5 mg at 10 mg/mL and 10 mg at 20 mg/mL.1 Half a millilitre is also the volume of every brand-name Zepbound single-dose vial, whatever its strength.2
How many mg is 25 or 30 units of tirzepatide?
25 units (0.25 mL) is 2.5 mg at 10 mg/mL; 30 units (0.3 mL) is 3 mg at 10 mg/mL and 6 mg at 20 mg/mL.1
How brand-name Zepbound is measured
Brand-name Zepbound is dosed in milligrams and millilitres, not units, and each presentation holds a fixed volume per dose.2 Single-dose pens and single-dose vials hold each strength, from 2.5 mg to 15 mg, in 0.5 mL.2 The multi-dose vial and the KwikPen hold four doses of 0.6 mL each, at concentrations from 4.17 mg/mL for the 2.5 mg strength to 25 mg/mL for the 15 mg strength.2
For vials, the label tells patients to use a syringe suited to the dose, for example a 1 mL syringe that can measure 0.5 mL or 0.6 mL.2 The single-dose vial instructions have the patient draw to the 0.5 mL line.3 On a U-100 syringe, 0.5 mL is the 50-unit mark and 0.6 mL is the 60-unit mark.1 To see where brand-name Zepbound costs least without insurance, see our cheapest Zepbound options. For the full schedule, see our Zepbound dosage guide and how to inject Zepbound.
Compounded tirzepatide: why a dosage calculator is not enough
Compounded tirzepatide is not FDA-approved, so there is no FDA-reviewed concentration, syringe or dosing chart for it.4 The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.4 It has also reported adverse events from patients measuring the wrong dose and from prescriptions above the doses in the approved labels.4 The FDA has determined that the tirzepatide injection shortage is resolved, which narrowed when pharmacies may make copies.5
A calculator only removes arithmetic errors. Four checks matter more:
- Read the concentration on the vial label, not from memory or an old prescription.
- Confirm the dose in both mg and units with the pharmacist who dispensed the vial.
- Use the syringe size you were given. The FDA asks providers to supply the right syringe for the intended dose and to teach patients how to measure it.1
- Discard multi-dose vials on schedule. The FDA advises throwing a vial away 28 days after first use, even if medication remains.4
Our explainer on compounded tirzepatide covers the legal status in more detail. If you are comparing pharmacy-made vials on price, see our cheapest compounded tirzepatide programs.
FAQ
Is 50 units of tirzepatide a lot? It depends on the concentration. 50 units is 0.5 mL, which is 5 mg at 10 mg/mL but 10 mg at 20 mg/mL.1 The approved tirzepatide doses run from 2.5 mg to a 15 mg weekly maximum.2
How many mL is 2.5 mg of tirzepatide? In a brand-name Zepbound single-dose pen or vial, 2.5 mg is 0.5 mL; in the multi-dose vial or KwikPen it is 0.6 mL.2 In a compounded vial, divide 2.5 by the mg/mL on the label.
Is 2.5 mg of tirzepatide a lot? No. 2.5 mg is the lowest FDA-approved tirzepatide dose and is used only for the first 4 weeks.2
How many mg of tirzepatide should I take? Only your prescriber can answer that. The Zepbound label starts at 2.5 mg weekly, steps up by 2.5 mg after at least 4 weeks, and lists 5 mg, 10 mg or 15 mg as maintenance doses for weight reduction.2
Can I use a 0.3 mL or 0.5 mL insulin syringe? Use the size your prescriber or pharmacist supplied. Smaller syringes use the same U-100 unit marks but hold less, and the FDA links dosing errors to using syringes that do not match the dose.1
Next step
If you are choosing between a compounded vial and a brand-name pen, compare compounded tirzepatide vs Zepbound and see our compounded tirzepatide rankings. For brand-name pricing by dose, see Zepbound cost, or compare prescribers on getting tirzepatide online. The semaglutide version of this guide is semaglutide units to mg.
This article is for information only and is not medical advice. The conversion tables are arithmetic examples, not prescriptions. Never change your dose or convert units without your prescriber or pharmacist, and always use the concentration printed on your own vial.
- 1.FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide productsSafety alert on units, milliliters and syringe confusion, July 26, 2024U.S. Food and Drug Administration↩
- 2.Zepbound (tirzepatide) injection, prescribing informationFull US prescribing information, revised 08/2026Eli Lilly and Company↩
- 3.Zepbound single-dose vial, Instructions for UseFDA-approved instructions for drawing a 0.5 mL doseEli Lilly and Company↩
- 4.FDA's concerns with unapproved GLP-1 drugs used for weight lossCompounded drugs are not FDA approved; dosing errors and multi-dose vial handlingU.S. Food and Drug Administration↩
- 5.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilizeThe tirzepatide and semaglutide shortage resolutionsU.S. Food and Drug Administration↩
- 6.Mounjaro (tirzepatide) injection, prescribing informationFull US prescribing information, revised 08/2026Eli Lilly and Company↩
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.